- Home
- DBL vs CYRX Comparison
DBL vs CYRX Comparison
Compare DBL & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBL
- CYRX
- Stock Information
- Founded
- DBL 2011
- CYRX 1999
- Country
- DBL United States
- CYRX United States
- Employees
- DBL N/A
- CYRX N/A
- Industry
- DBL
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- DBL
- CYRX Health Care
- Exchange
- DBL Nasdaq
- CYRX Nasdaq
- Market Cap
- DBL 280.4M
- CYRX 277.5M
- IPO Year
- DBL N/A
- CYRX N/A
- Fundamental
- Price
- DBL $15.50
- CYRX $7.07
- Analyst Decision
- DBL
- CYRX Strong Buy
- Analyst Count
- DBL 0
- CYRX 8
- Target Price
- DBL N/A
- CYRX $10.75
- AVG Volume (30 Days)
- DBL 61.0K
- CYRX 432.2K
- Earning Date
- DBL 01-01-0001
- CYRX 05-07-2025
- Dividend Yield
- DBL 8.67%
- CYRX N/A
- EPS Growth
- DBL N/A
- CYRX N/A
- EPS
- DBL N/A
- CYRX N/A
- Revenue
- DBL N/A
- CYRX $232,134,000.00
- Revenue This Year
- DBL N/A
- CYRX N/A
- Revenue Next Year
- DBL N/A
- CYRX $8.19
- P/E Ratio
- DBL N/A
- CYRX N/A
- Revenue Growth
- DBL N/A
- CYRX 3.16
- 52 Week Low
- DBL $13.75
- CYRX $4.58
- 52 Week High
- DBL $15.70
- CYRX $16.89
- Technical
- Relative Strength Index (RSI)
- DBL 50.86
- CYRX 67.38
- Support Level
- DBL $15.13
- CYRX $5.43
- Resistance Level
- DBL $15.65
- CYRX $6.00
- Average True Range (ATR)
- DBL 0.18
- CYRX 0.47
- MACD
- DBL 0.02
- CYRX 0.16
- Stochastic Oscillator
- DBL 65.12
- CYRX 91.53
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.